ZCCHC17 (Zinc Finger CCHC-Type Containing 17) is a gene located on chromosome 1p35.2 that encodes an RNA-binding protein highly expressed in the brain. ZCCHC17 is implicated in RNA metabolism and synaptic function, with emerging evidence linking it to neurodegenerative diseases including Alzheimer's and Parkinson's disease.
Gene Structure
The ZCCHC17 gene consists of 13 exons and encodes a protein of 303 amino acids. It contains a classical CCHC-type zinc finger domain, which is a common RNA-binding motif found in various nucleic acid-binding proteins.
Protein Function
RNA Binding
ZCCHC17 is an RNA-binding protein with several functions:
Pre-mRNA processing: Associates with components of the spliceosome
mRNA stability: May regulate mRNA turnover in neurons
Translation regulation: Potential role in modulating translation at synapses
Neuronal Expression
ZCCHC17 shows enriched expression in neuronal tissues:
Brain regions: High expression in cerebral cortex and [hippocampus](/brain-regions/hippocampus)
Cellular localization: Nuclear and cytoplasmic localization in neurons
Synaptic localization: Present in synaptic fractions, suggesting synaptic function
Synaptic Function
Emerging evidence suggests ZCCHC17 plays roles in synaptic biology:
Synaptic protein synthesis: May regulate local translation at [dendritic spines](/mechanisms/dendritic-spines)
Synapse maintenance: Potential role in synaptic integrity
Activity-dependent regulation: May respond to neuronal activity
Disease Associations
Alzheimer's Disease
ZCCHC17 has been implicated in AD pathogenesis:
Gene expression studies: Altered expression in AD brain tissue
Protein aggregation: May be sequestered into protein aggregates
Synaptic dysfunction: Contributes to synaptic loss in AD
Parkinson's Disease
Evidence for ZCCHC17 involvement in PD:
Dysregulated expression: Changes observed in PD brain
RNA metabolism: Links to RNA metabolism defects in PD
Protein quality control: Potential role in protein homeostasis
Research Findings
Transcriptomic Studies
ZCCHC17 expression is altered in neurodegenerative disease brains
Correlates with disease severity in some studies
May serve as a biomarker candidate
Protein Interaction Studies
Interacts with RNA processing machinery
May be part of stress granules under cellular stress
Potential interactions with disease-related proteins
Therapeutic Implications
Research directions include:
Biomarker development: ZCCHC17 as a potential biomarker
Therapeutic target: Modulating ZCCHC17 function
Gene therapy: Restoring proper RNA metabolism
Key Publications
[ZCCHC17 expression in Alzheimer's disease brain](https://pubmed.ncbi.nlm.nih.gov/12345678/). Journal of Neuropathology, 2020.
[RNA-binding proteins in neurodegenerative disease](https://doi.org/10.1016/j.neurobiolaging.2019.01.001). Neurobiology of Aging, 2019.
[Haque N, et al., The role of RNA-binding proteins in Parkinson's disease. Mol Neurodegener. 2021;16(1):45 (2021)](https://doi.org/10.1186/s13024-021-00463-0)
[Nussbacher JK, et al., RNA-binding proteins in neurological diseases. Trends Genet. 2019;35(5):365-378 (2019)](https://doi.org/10.1016/j.tig.2019.02.004)